Literature DB >> 25585955

Microcosmic mechanism of dication for inhibiting acylation of acidic Peptide.

Feng Qi1, Liuqing Yang, Jie Wu, Guanghui Ma, Zhiguo Su.   

Abstract

PURPOSE: For long-effective peptide formulation based on poly(D,L-lactic-co-glycolic acid) (PLGA) microspheres, acylation often leads to peptide instability during its release and reduced drug efficacy. Among the reported solving strategies, adding dication such as Ca(2+) and Mn(2+) in the formulation was the most convenient method for inhibiting basic peptide acylation. However, the strategies for the acidic peptide still remain unexplored, possibly due to the peptide's changeable charge state in acid environment within degraded PLGA microspheres. Moreover, the previous studies mainly focusing on the macroscopical adsorption of peptide to PLGA cannot demonstrate the inhibition mechanism.
METHODS: Acylation inhibition for acidic peptide (exenatide) by dications (Ca(2+), Mn(2+) and Zn(2+)) was studied for the first time, and Quartz Crystal Microbalance with Dissipation (QCM-D) was innovatively employed to analyze microcosmic mechanism of the inhibition.
RESULTS: These dications played different roles in acylation inhibition of acidic peptide. The effects of dications on acylation outside or inside PLGA microspheres indicated that Ca(2+) did not work, Mn(2+) played a weak role, and Zn(2+) possessed the greatest inhibition.
CONCLUSIONS: Zn(2+) was the most effective dication for the acylation inhibition because of the complex formation and its steric-hindrance effect, which was a new function for this dication.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25585955     DOI: 10.1007/s11095-015-1622-5

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  22 in total

Review 1.  Protein instability in poly(lactic-co-glycolic acid) microparticles.

Authors:  M van de Weert; W E Hennink; W Jiskoot
Journal:  Pharm Res       Date:  2000-10       Impact factor: 4.200

2.  Multilayer nanoparticles for sustained delivery of exenatide to treat type 2 diabetes mellitus.

Authors:  Jae Yeon Kim; Hwanbum Lee; Keun Sang Oh; Seho Kweon; Ok-cheol Jeon; Youngro Byun; Kwangmeyung Kim; Ick Chan Kwon; Sang Yoon Kim; Soon Hong Yuk
Journal:  Biomaterials       Date:  2013-07-26       Impact factor: 12.479

3.  In vitro and in vivo evaluation of a once-weekly formulation of an antidiabetic peptide drug exenatide in an injectable thermogel.

Authors:  Lin Yu; Kun Li; Xiaojun Liu; Chang Chen; Yongchu Bao; Tianyuan Ci; Qinghua Chen; Jiandong Ding
Journal:  J Pharm Sci       Date:  2013-09-24       Impact factor: 3.534

4.  Peptide acylation by poly(alpha-hydroxy esters).

Authors:  Andrea Lucke; Josef Kiermaier; Achim Göpferich
Journal:  Pharm Res       Date:  2002-02       Impact factor: 4.200

5.  Preparation of uniform-sized exenatide-loaded PLGA microspheres as long-effective release system with high encapsulation efficiency and bio-stability.

Authors:  Feng Qi; Jie Wu; Qingze Fan; Fan He; Guifang Tian; Tingyuan Yang; Guanghui Ma; Zhiguo Su
Journal:  Colloids Surf B Biointerfaces       Date:  2013-09-07       Impact factor: 5.268

Review 6.  Protein-GAG interactions: new surface-based techniques, spectroscopies and nanotechnology probes.

Authors:  E A Yates; C J Terry; C Rees; T R Rudd; L Duchesne; M A Skidmore; R Lévy; N T K Thanh; R J Nichols; D T Clarke; D G Fernig
Journal:  Biochem Soc Trans       Date:  2006-06       Impact factor: 5.407

7.  The effect of poly(ethylene glycol)-poly(D,L-lactic acid) diblock copolymers on peptide acylation.

Authors:  Andrea Lucke; Elisabetta Fustella; Jörg Tessmar; Andrea Gazzaniga; Achim Göpferich
Journal:  J Control Release       Date:  2002-04-23       Impact factor: 9.776

8.  Identification of chemically modified peptide from poly(D,L-lactide-co-glycolide) microspheres under in vitro release conditions.

Authors:  Santos B Murty; Jack Goodman; B C Thanoo; Patrick P DeLuca
Journal:  AAPS PharmSciTech       Date:  2003-10-13       Impact factor: 3.246

9.  A long-acting formulation of a polypeptide drug exenatide in treatment of diabetes using an injectable block copolymer hydrogel.

Authors:  Kun Li; Lin Yu; Xiaojun Liu; Chang Chen; Qinghua Chen; Jiandong Ding
Journal:  Biomaterials       Date:  2013-01-23       Impact factor: 12.479

10.  Development of a sustained-release recombinant human growth hormone formulation.

Authors:  H H Kwak; W S Shim; M K Choi; M K Son; Y J Kim; H C Yang; T H Kim; G I Lee; B M Kim; S H Kang; C K Shim
Journal:  J Control Release       Date:  2009-03-28       Impact factor: 9.776

View more
  1 in total

1.  Reversible hydrophobic ion-paring complex strategy to minimize acylation of octreotide during long-term delivery from PLGA microparticles.

Authors:  Ravi D Vaishya; Abhirup Mandal; Mitan Gokulgandhi; Sulabh Patel; Ashim K Mitra
Journal:  Int J Pharm       Date:  2015-05-01       Impact factor: 5.875

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.